South Dakota Investment Council Biogen Inc. Transaction History

South Dakota Investment Council

$4.88 Billion
Q2 2024

A detailed history of South Dakota Investment Council transactions in Biogen Inc. stock. As of the latest transaction made, South Dakota Investment Council holds 3,613 shares of BIIB stock, worth $627,903. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,613

Previous 3,619 0.17%

Holding current value

$627,903

Previous $780,000 7.44%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $1,143 - $1,420	-6 Reduced 0.17%	3,613 $838,000
Q3 2023 Nov 07, 2023	SELL	$253.3 - $285.89 $50,660 - $57,178	-200 Reduced 5.24%	3,619 $930,000
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $55,050 - $63,612	-200 Reduced 4.98%	3,819 $1.09 Million
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $585,185 - $737,302	-3,020 Reduced 42.9%	4,019 $846,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $113,196 - $147,620	400 Added 6.03%	7,039 $1.99 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $139,860 - $223,943	-540 Reduced 7.52%	6,639 $2.3 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $2.55 Million - $2.99 Million	-10,500 Reduced 59.39%	7,179 $2.01 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $2.48 Million - $3.73 Million	10,500 Added 146.26%	17,679 $4.33 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $283,303 - $327,109	-1,070 Reduced 12.97%	7,179 $2.04 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $2,957 - $3,751	-11 Reduced 0.13%	8,249 $2.61 Million
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $160,643 - $221,971	-730 Reduced 8.12%	8,260 $2.45 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $257,666 - $288,997	-1,185 Reduced 11.65%	8,990 $2.09 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $6.24 Million - $6.87 Million	-28,441 Reduced 73.65%	10,175 $2.38 Million
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $5.48 Million - $8.57 Million	-25,270 Reduced 39.55%	38,616 $9.13 Million
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $1.03 Million - $1.31 Million	-3,700 Reduced 5.47%	63,886 $19.2 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $359,549 - $470,191	-1,225 Reduced 1.78%	67,586 $23.9 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $296,148 - $352,946	1,150 Added 1.7%	68,811 $20 Million
Q1 2018 May 10, 2018	BUY	$260.13 - $367.91 $5.79 Million - $8.19 Million	22,266 Added 49.05%	67,661 $18.5 Million
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $2.69 Million - $3.02 Million	-8,750 Reduced 16.16%	45,395 $14.5 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $15.2 Million - $17.9 Million	54,145	54,145 $17 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council Biogen Inc. Transaction History